Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews
- PMID: 30629654
- PMCID: PMC6328162
- DOI: 10.1371/journal.pone.0210312
Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews
Abstract
Introduction: Medication review (MR) is a pharmacy practice conducted in different settings that has a positive impact on patient health outcomes. In this context, systematic reviews on MR have restricted the assessment of this practice using criteria such as methodological quality, practice settings, and patient outcomes. Therefore, expanding research on this subject is necessary to facilitate the understanding of the effectiveness of MR and the comparison of its results.
Aim: To examine the panorama of systematic reviews on pharmacist-participated MR in different practice settings.
Methods: A literature search was undertaken in Biblioteca Virtual em Saúde (BVS), Embase, PubMed, Scopus, The Cochrane Library, and Web of Science databases through January 2018 using keywords for "medication review", "systematic review", and "pharmacist". Two independents investigators screened titles, abstracts, full texts; assessed methodological quality; and, extracted data from the included reviews.
Results: Seventeen systematic reviews were included, of which sixteen presented low to moderate methodological quality. Most of reviews were conducted in Europe (n = 7), included controlled primary studies (n = 16), elderly patients (n = 9), and long-term care facilities (n = 8). Seven reviews addressed MR as an intervention and thirteen reviews cited collaboration between physicians and pharmacists in the practice of MR. In addition, thirteen terminologies for MR were used and the main objective was to identify and solve drug-related problems and/or optimize the drug use (n = 11).
Conclusion: There is considerable heterogeneity in practice settings, population, definitions, terminologies, and approach of MR as well as poor description of patient care process in the systematic reviews. These facts may limit the comparison, summarization and understanding of the results of MR. Furthermore, the methodological quality of most systematic reviews was below ideal. Thus, international agreement on the MR process is necessary to assess, compare and optimize the quality of care provided.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Pharmacist-led medication review in community settings: An overview of systematic reviews.Res Social Adm Pharm. 2017 Jul-Aug;13(4):661-685. doi: 10.1016/j.sapharm.2016.08.005. Epub 2016 Aug 28. Res Social Adm Pharm. 2017. PMID: 27665364 Review.
-
Impact of medication reconciliation on health outcomes: An overview of systematic reviews.Res Social Adm Pharm. 2020 Aug;16(8):995-1002. doi: 10.1016/j.sapharm.2019.10.011. Epub 2019 Oct 17. Res Social Adm Pharm. 2020. PMID: 31883776
-
Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review.JBI Database System Rev Implement Rep. 2018 Sep;16(9):1823-1873. doi: 10.11124/JBISRIR-2017-003697. JBI Database System Rev Implement Rep. 2018. PMID: 30204671
-
The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.Prim Care Diabetes. 2020 Oct;14(5):393-400. doi: 10.1016/j.pcd.2019.12.007. Epub 2020 Jan 8. Prim Care Diabetes. 2020. PMID: 31926868
-
Impact of pharmaceutical care for asthma patients on health-related outcomes: An umbrella review.Pharmacol Res Perspect. 2024 Jun;12(3):e1195. doi: 10.1002/prp2.1195. Pharmacol Res Perspect. 2024. PMID: 38644566 Free PMC article.
Cited by
-
Medication Review and Enhanced Information Transfer at Discharge of Older Patients with Polypharmacy: a Cluster-Randomized Controlled Trial in Swiss Hospitals.J Gen Intern Med. 2023 Feb;38(3):610-618. doi: 10.1007/s11606-022-07728-6. Epub 2022 Aug 31. J Gen Intern Med. 2023. PMID: 36045192 Free PMC article. Clinical Trial.
-
A pharmacist-led medication review service with a deprescribing focus guided by implementation science.Front Pharmacol. 2023 Jan 30;14:1097238. doi: 10.3389/fphar.2023.1097238. eCollection 2023. Front Pharmacol. 2023. PMID: 36794277 Free PMC article.
-
'He or she maybe doesn't know there is such a thing as a review': A qualitative investigation exploring barriers and facilitators to accessing medication reviews from the perspective of people from ethnic minority communities.Health Expect. 2022 Aug;25(4):1432-1443. doi: 10.1111/hex.13482. Epub 2022 Apr 5. Health Expect. 2022. PMID: 35384182 Free PMC article.
-
Innovating medication reviews through a technology-enabled process.Res Social Adm Pharm. 2022 Apr;18(4):2700-2705. doi: 10.1016/j.sapharm.2021.07.019. Epub 2021 Jul 24. Res Social Adm Pharm. 2022. PMID: 34326004 Free PMC article.
-
The impact of clinical pharmacist services on patient health outcomes in Pakistan: a systematic review.BMC Health Serv Res. 2021 Aug 23;21(1):859. doi: 10.1186/s12913-021-06897-0. BMC Health Serv Res. 2021. PMID: 34425816 Free PMC article.
References
-
- Pharmaceutical Care Network Europe. Medication review definition approved. 2016 Feb 20 [cited 10 March 2016]. In: Pharmaceutical Care Network Europe Website [Internet]. Europe: Pharmaceutical Care Network Europe (PCNE) 2016. http://www.pcne.org/news/35/medication-review-definition-approved.
-
- Clyne W, Blenkinsopp A, Seal R. A guide to medication review. London: National Prescribing Centre (NPC), 2008.
-
- Pharmacy Council of New Zealand. Medicines management: definition, levels, competence framework. Wellington: Pharmacy Council of New Zealand; 2006.
-
- American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008;48(3): 341–353. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources